Zhejiang Orient Gene Biotech Co.Ltd(688298) release the first quarterly report and annual report. In the first quarter of 2022, the net profit was RMB 2.067 billion, a year-on-year increase of 74.20%. The basic earnings per share is 17.22 yuan.
In 2021, the net profit was 4.92 billion yuan, a year-on-year increase of 193.33%. The basic earnings per share is 41 yuan. The company plans to distribute a cash dividend of 61.8 yuan (including tax) for every 10 shares and increase 4 shares for every 10 shares.
